Dietary cholesterol in alcohol-associated liver disease

被引:0
|
作者
Jia, Lin [1 ]
机构
[1] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA
基金
美国国家卫生研究院;
关键词
alcohol; alcohol-associated liver disease; cholesterol; cholesterol-lowering pharmacotherapies; GENETIC POLYMORPHISMS; METABOLIZING ENZYMES; INSULIN-RESISTANCE; HEPATIC STEATOSIS; REDUCING LIPIDS; FATTY LIVER; RAT MODEL; ETHANOL; EZETIMIBE; INHIBITION;
D O I
10.1097/IN9.0000000000000026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is an increasing prevalence of alcohol-associated liver disease (ALD) worldwide. In addition to excessive alcohol consumption, other nutritional factors have been shown to affect the initiation and progression of ALD. The emerging role of cholesterol in exacerbating ALD has been reported recently and the underlying mechanisms are discussed. In addition, the interplay between dietary cholesterol and alcohol on cholesterol metabolism is reviewed. Furthermore, we highlight the therapeutic potential of cholesterol-lowering drugs in managing the onset and severity of ALD. Finally, we suggest the future mechanistic investigation of the effect of cholesterol on insulin resistance and intestinal inflammation in the exacerbation of alcohol-induced cellular and systemic dysfunction.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Alcohol-associated liver disease and public health policies
    Sengupta, Shreya
    Gill, Victoria
    Mellinger, Jessica L.
    HEPATOLOGY, 2024, 80 (06) : 1323 - 1341
  • [42] Alcohol-associated liver disease-Global epidemiology
    Aberg, Fredrik
    Jiang, Z. Gordon
    Cortez-Pinto, Helena
    Mannisto, Ville
    HEPATOLOGY, 2024, 80 (06) : 1307 - 1322
  • [43] Primed for the spotlight: Transplantation for alcohol-associated liver disease
    Im, Gene Y.
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 253 - 254
  • [44] Programmed cell death in alcohol-associated liver disease
    Miyata, Tatsunori
    Nagy, Laura E.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 618 - 625
  • [45] Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
    Prince, David Stephen
    Nash, Emily
    Liu, Ken
    DRUGS, 2023, 83 (16) : 1459 - 1474
  • [46] A Review of the Diagnosis and Treatment of Alcohol-Associated Liver Disease
    Conteh, Lanla
    Levin, Douglas
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (19): : 1976 - 1976
  • [47] Targeting pathobionts for the treatment of alcohol-associated liver disease
    Lang, Sonja
    Demir, Muenevver
    Schnabl, Bernd
    LIVER INTERNATIONAL, 2021, 41 (01) : 239 - 240
  • [48] From intestinal dysbiosis to alcohol-associated liver disease
    Mendes, Beatriz Garcia
    Schnabl, Bernd
    CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 595 - 605
  • [49] ACG Clinical Guideline: Alcohol-Associated Liver Disease
    Jophlin, Loretta L.
    Singal, Ashwani K.
    Bataller, Ramon
    Wong, Robert J.
    Sauer, Bryan G.
    Terrault, Norah A.
    Shah, Vijay H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (01): : 30 - 54
  • [50] Current Medical Treatment for Alcohol-Associated Liver Disease
    Ayares, Gustavo
    Idalsoaga, Francisco
    Diaz, Luis A.
    Arnold, Jorge
    Arab, Juan P.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (05) : 1333 - 1348